December 3rd, 2007 Posted by: Dr. Dobson
Two teams of scientists simultaneously announced they have reprogrammed human skin cells to obtain pluripotency, the characteristic hailed in embryonic stem cells as having the potential for therapeutic breakthroughs in areas ranging from Parkinson’s disease to diabetes.
Scientists in Japan and Wisconsin created the so-called induced pluripotent cells by introducing different combinations of genes into skin cells that are normally switched off after embryonic cells differentiate into various cell types. The results were published last month in Read the rest of this entry »
Popularity: unranked [?]
Tags:
breakthrough,
cells,
rather,
embryos
Posted in News in Science | No Comments »
November 30th, 2007 Posted by: Dr. Dobson
Tomorrow is World AIDS Day and instead of “barraging you with [another set of] statistics, gruesome photos, or heart-wrenching stories” (quote credit to Mr. Casnocaha), I want to alert you to something we prefer here - solutions, problem solving, technology, and creative thinking. Piya Sorcar, a doctoral student in Stanford’s Learning, Sciences & Technology Design program has used her considerable skills to figure out how to reach the minds of children in devleoping countries when it comes to HIV/AIDS education.
Read the rest of this entry »
Popularity: unranked [?]
Tags:
World,
Educational,
Breakthrough
Posted in Men`s Health, News in Science, Lab Medicine | No Comments »
November 24th, 2007 Posted by: Dr. Dobson
If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!
transplants, liver transplants, heart transplants, pancreas and lung risk human papillomavirus (HPV) strains known to cause cervical cancer. A screening test s sensitivity is
www.cancer.gov
Read the rest of this entry »
Popularity: unranked [?]
Tags:
BreakThrough,
Digest,
Study,
beats,
detecting,
cervical,
Equate,
Allergies
Posted in Medical Industry, Drugs, Medicine | No Comments »
November 18th, 2007 Posted by: Dr. Dobson
An anti-psychotic drug already approved in the U.S. to treat adults and adolescents with schizophrenia may soon be available for youngsters age 10 to 17 years of age suffering from bipolar disorder.
The U.S. Food and Drug Administration (FDA) has given priority review status to the drug Abilify which is manufactured by Bristol-Myers Squibb and Otsuka Pharmaceutical.
Read the rest of this entry »
Popularity: unranked [?]
Tags:
Breakthrough,
innovation,
sensitivity,
Malaria,
diagnostics
Posted in Men`s Health, Drugs, Medicine, Lab Medicine, Pediatrics, Pharmacists | No Comments »